During a pause in its appraisal by NICE the drug, palbociclib (Ibrance), is being made available to suitable secondary breast cancer patients. Our Clinical Nurse Specialist for Secondary Beast Cancer, Catherine Priestley explains more.
Healthcare Professional | 5 May 2017
Nearly half of all hospitals are failing to provide specialist support for people living with secondary breast cancer. We spoke to Tracy, a secondary breast specialist cancer nurse, about the importance of providing support to women living with the condition.
Healthcare Professional | 21 April 2017